← k3vl4r
Log inGet started →

ELDN (Eledon Pharmaceuticals Inc) Price Forecast

AI-generated price forecast for Eledon Pharmaceuticals Inc (ELDN) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ELDN as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 1.98. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

1.98

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ELDN forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-37.63%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ELDN's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ELDN news

From the market-news feed the forecasts are read against.

  • Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights · Yahoo · Nov 12
  • Eledon Pharma Q3 Adj. EPS $(0.16) Beats $(0.19) Estimate · Benzinga · Nov 12
  • Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting · Yahoo · Oct 26
  • Eledon Pharma Reports Improved Quality Of Life And Reduced Symptom Burden With Tegoprubart In Kidney Transplant Patients At ASN Kidney Week 2026 · Benzinga · Oct 26

🔒

See the full ELDN forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ELDN forecast — frequently asked

Will ELDN go up?

K3vl4r's calibrated AI forecast currently reads ELDN as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ELDN price prediction for 2026?

K3vl4r's model projects ELDN toward $1.23 over the next ~4 weeks, a -37.6% move from $1.98. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

HQYOCULGUTSIRDARWRTOVXANVSWAYAHCOMANECANFCRSPHLNSTIM

Will ELDN reach…?

Will ELDN reach $3.00?Will ELDN reach $5.00?Will ELDN reach $10.00?

Or see the full ELDN price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ELDN

ELDN vs HQYELDN vs OCULELDN vs GUTSELDN vs IRDELDN vs ARWRELDN vs TOVX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.